Latest Breaking News On - Eric poma - Page 1 : comparemela.com

Molecular Templates, Inc Reports First Quarter 2024 Financial Results and Corporate Update

Molecular Templates, Inc Reports First Quarter 2024 Financial Results and Corporate Update
marketscreener.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from marketscreener.com Daily Mail and Mail on Sunday newspapers.

United statesEric pomaExchange commissionGlobenewswire incMolecular templates incSan diego convention centerChief executiveChief scientific officerDiego convention centerEngineered toxin bodiesLooking statementsPrivate securities litigation reform actSafe harborMolecular template

Molecular Templates, Inc Reports First Quarter 2024

Molecular Templates, Inc Reports First Quarter 2024
globenewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from globenewswire.com Daily Mail and Mail on Sunday newspapers.

United statesEric pomaExchange commissionMolecular templates incSan diego convention centerChief executiveChief scientific officerEngineered toxin bodiesLooking statementsPrivate securities litigation reform actMolecular templatesSafe harborMolecular template

Molecular Templates Presents Interim Data from MT-6402

AUSTIN, Texas, April 09, 2024 (GLOBE NEWSWIRE) Molecular Templates, Inc. (Nasdaq: MTEM, “Molecular Templates,” or “MTEM”), a clinical-stage.

United statesSan diegoEric pomaMolecular templates incExchange commissionAmerican association for cancer research annual meetingInterim dataCancer research annual meetingShiga like toxinLooking statementsPrivate securities litigation reform actMolecular templatesSafe harborMolecular templateNasdaq mtemMolecular templates

Molecular Templates (MTEM) Presents Interim Data from MT-6402 Phase I Study in Patients with PD-L1+ Solid Tumors at AACR

Molecular Templates (MTEM) Presents Interim Data from MT-6402 Phase I Study in Patients with PD-L1+ Solid Tumors at AACR
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesSan diegoEric pomaMolecular templates incAmerican association for cancer research annual meetingMolecular templatesInterim dataCancer research annual meetingInterim data location

What s Going On With Molecular Templates Stock? - Molecular Templates (NASDAQ:MTEM)

Molecular Templates shares are volatile Tuesday after the company presented interim data from MT-6402 Phase I study in patients with PD-L1+ solid tumors. Molecular Templates said the findings show that MT-6402 acts uniquely from other approved checkpoint agents and was well-tolerated with no drug-related Grade 4 or Grade 5 adverse events observed. "We are excited to see objective responses in heavily pre-treated, checkpoint-experienced, head and neck cancer patients, a setting with high unmet medical need," said CEO Eric Poma.

Eric pomaLufax holdingBenzinga proGoing on with sofi technologiesMolecular templates